`

Oniria Therapeutics

Biotechnology Research

Specialities :
Biotechnology
Cancer
Cell dormancy
First-in-class
Biopharmaceutical

+5

revenue-icon Revenue
11M - 100M
funding-icon Total Funding
$1.4M
size-icon Size
11 - 50

Frequently Asked Questions About Oniria Therapeutics

What does Oniria therapeutics do?+

A shift in cancer treatment methodology makes a world of difference. Oniria Therapeutics is a spin-off from Vall dHebron Institute of Oncology (VHIO), the University of Barcelona (UB) and the Catalan Institution for Research and Advanced Studies (ICREA). Oniria Therapeutics is a biotech company focused on the development of first-in-class drugs in the field of precision oncology. It develops therapies to modulate and eliminate dormant tumor cells as a novel targeted strategy to overcome their persistence. Our flagship product allosterically activates TET2, a master epigenetic enzyme

What are Oniria therapeutics's specialties? +

Biotechnology,cancer,cell dormancy,first-in-class,biopharmaceutical,precision oncology,cancer persistence,spin-off,targeted therapy,and tet2

What is Oniria therapeutics's industry? +

Oniria therapeutics operates in the Biotechnology research industry.

What is Oniria therapeutics's revenue? +

Oniria therapeutics's revenue is 11m - 100m

What is Oniria therapeutics's company size? +

Oniria therapeutics has 11 - 50 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.